Zonisamide + Placebo
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Sleep Apnea
Conditions
Sleep Apnea, Obstructive Sleep Apnea, Obesity
Trial Timeline
Mar 1, 2010 → Jun 1, 2013
NCT ID
NCT01765608About Zonisamide + Placebo
Zonisamide + Placebo is a phase 2 stage product being developed by Eisai for Sleep Apnea. The current trial status is completed. This product is registered under clinical trial identifier NCT01765608. Target conditions include Sleep Apnea, Obstructive Sleep Apnea, Obesity.
What happened to similar drugs?
20 of 20 similar drugs in Sleep Apnea were approved
Approved (20) Terminated (2) Active (0)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01765608 | Phase 2 | Completed |
| NCT00566254 | Phase 3 | Completed |
| NCT00692003 | Phase 3 | Terminated |
| NCT00693017 | Phase 3 | Terminated |
| NCT00327717 | Phase 3 | Completed |
Competing Products
20 competing products in Sleep Apnea